Opticross 6
Payments companies reported to CMS as associated with Opticross 6. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Opticross 6, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Opticross 6
These are the largest totals companies reported as associated with Opticross 6. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Seyed Mohammad Khalafi | Fort Worth, TX | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $492.47 |
| Alisa Thamwiwat | Bedford, TX | Interventional Cardiology | $353.52 |
| Aiswarya Sundaram | Arlington, TX | Interventional Cardiology | $261.87 |
| Karthik Anand | Fort Worth, TX | Interventional Cardiology | $249.09 |
| Nethuja Salagundla | Lafayette, LA | Internal Medicine | $249.09 |
| Scott Ewing | Fort Worth, TX | Interventional Cardiology | $237.34 |
| Majid Asawaeer | Fort Worth, TX | Interventional Cardiology | $237.34 |
| Jodi Wurst | Fort Worth, TX | Family | $219.79 |
| Anas Hamadeh | Fort Worth, TX | Cardiovascular Disease | $199.75 |
| Tanvir Bajwa | Park Ridge, IL | Cardiovascular Disease | $145.53 |
Prescribed Opticross 6?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.